Journals / İstanbul Medical Journal / 2013 / Cilt: 14 - Sayı: 3

Septoplasti Operasyonu Yapılan Charcot-Marie-Tooth Hastasında Anestezi

Anesthesic Management of a Patient with Carcot-Marie-Tooth Disease Who Underwent Septoplasty

Pages
73–75
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aim to show the complications and circumtances and to emphasize the factors to be considered in anesthesia managment of a patient with CMT disoder who undergo a a septoplasty operation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Charcot-Marie-Tooth is genetic polineuorpathic disorder with autosomal dominant transition.
📊
Key Findings & Data:It usually starts between 20-30 years of age.
💡
Conclusion & Impact:We aim to show the complications and circumtances and to emphasize the factors to be considered in anesthesia managment of a patient with CMT disoder who undergo a a septoplasty operation
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Charcot-Marie-Tooth is genetic polineuorpathic disorder with autosomal dominant transition. It usually starts between 20-30 years of age. Its frequency is about 1/2500-4000. It starts in distal foot muscles and the forearm and can spread to the whole body. Symptoms are, movement disorders, low foot, neuromotor debility and sensorial ataxy. We aim to show the complications and circumtances and to emphasize the factors to be considered in anesthesia managment of a patient with CMT disoder who undergo a a septoplasty operation

Özet

Charcot-Marie-Tooth (CMT) otozomal dominant geçişli olan bir çeşit genetik polinöropati hastalığıdır. Genellikle 20-30 yaşlarında başlar. Sıklığı 1/2500-4000 arasındadır. Distal ayak kasları ve ön kolda başlar ve tüm vücudu sarabilir. Semptomlar; yürüme güçlüğü, düşük ayak, nöromotor debilite ve sensoriyal ataksidir. Biz septoplasti operasyonu olan CMT'li bir olguda Anestezi yönetiminde karşıaşılabileceğimiz durumlar, komplikasyonlar ve dikkat edilmesi gereken noktaları vurgulamayı amaçladık.

🔖

Cite This Article

ÖZYUVACI, E. N., DEMİRTÜRK, Z., SEVİM, A., USLU, N., AVCI, S. (2022). Septoplasti Operasyonu Yapılan Charcot-Marie-Tooth Hastasında Anestezi. İstanbul Medical Journal, Cilt: 14 - Sayı: 3, 73–75. https://ajindex.com/articles/552273

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Greenwood JJ, Scott WE. Charcot-Marie-Tooth disease: Peripartum management of two contrasting clinical cases. Int J Obstet Anesth 2007; 16: 149-54. [CrossRef] 2. Schmitt HJ, Wick S, Munster T. Onset and duration of mivacurium-induced neuromuscular blockade in children with Charcot-Marie-Tooth disease. A case series with five children. Pediatr Anesth 2006 16: 182-7. 3. Mendell J. Charcot Marie Tooth related disorders. Semin Neurol 1998; 18: 41-7. [CrossRef], 4. Schmitt HJ, Münster T. Mivacurium-induced neuromuscular block in adult patients suffering from Charcot-Marie-Tooth disease. Can J Anesth 2006; 53: 10: 984-8. [CrossRef] 5. Scaioli V, Pareyson D, Avanzini G, Sghirlanzoni A. F response and somatosensory and brainstem auditory evoked potential studies in HSMN type I and II. J Neurol Neurosurg Psychiatry 1992; 55: 1027-31. [CrossRef] 6. Kotani N, Hirota K, Anzawa N, Takamura K, Sakai T, Matsuki A. Motor and Sensory Disability Has a Strong Relationship to Induction Dose of Thiopental in Patients with the Hypertropic Variety of Charcot-MarieTooth Syndrome. Anesth Analg 1996; 82: 182-6. [CrossRef] 7. Fiacchino F, Grandi L, Ciano C, Sghirlanzoni A. Unrecognized Charcot-Marie-Tooth Disease: Diagnostic Difficulties in the Assessment of Recovery from Paralysis. Anesth Analg 1995; 81: 199-201. [CrossRef] 8. Pogson D, Telfer J, Winbush S. Prolonged vecuronium neuromuscular blockade associated with Charcot Marie Tooth neuropathy. Br J Anaesth 2000; 85: 914-7. [CrossRef] 9. Kotani N, Hirota K, Anzawa N, Takamura K, Sakai T, Matsuki A. Motor and Sensory Disability Has a Strong Relationship toInduction Dose of Thiopental in Patients with theHypertropic Variety of Charcot-MarieTooth Syndrome. Anesth Analg 1996; 82: 182-6. [CrossRef] 10. Naguib M, Samarkandi AH. Response to atracurium and mivacurium in a patient with Charcot Marie Tooth disease. Can J Anaesth 1998; 45: 56-9. [CrossRef] 11. Antognini JF. Anaesthesia for Charcot Marie Tooth disease: a review of 86 cases. Can J Anaesth 1992; 39: 398-400. [CrossRef]